Home

Mitchell Creem

CIK 1572821 · Chief Financial Officer · last filed 2023-06-15

Mitchell Creem is a Chief Financial Officer who has filed 11 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing shows the insider bought $21.4K of NUTX on Jun 15, 2023. Across all open-market trades the lifetime net is +$21.4K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $13.6M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$13.60M

Companies

2

Total Filings

11

Lifetime Open-Market Net

$21.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NUTX Director 81,746 $166.40 $13.60M $21.4K 4 2023-06-15
Astrana Health, Inc. (AMEH) Delisted Chief Financial Officer — $40.82 — $0 1 2015-07-29

Recent Filings

11 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-06-15 NUTX Buy (P) +50,000 $21.4K EDGAR
2022-12-30 NUTX Mixed — $82.5K EDGAR
2022-05-10 NUTX Grant (A) +21,208 $82.5K EDGAR
2022-04-08 NUTX Grant (A) — $0 EDGAR
2021-02-03 — Grant (A) — $0
2020-09-09 — Buy (P) +31,746 $634.92M
2020-06-18 — Grant (A) — $0
2020-04-28 — Grant (A) — $0
2015-07-29 Astrana Health, Inc. (AMEH) Delisted Grant (A) — $0 EDGAR
2015-01-09 — Grant (A) — $0
Showing 1–10 of 11
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.